Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma
Anticancer Research · 2024
DOI: 10.21873/anticanres.17352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Makoto Fujiwara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Oxidative Phosphorylation, Mitochondria, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan.
- Department of Pathology, Hiroshima University, Hiroshima, Japan.
- Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan; morihito@hiroshima-u.ac.jp.
Zitieren
APA
Fujiwara, M., Mimae, T., Kushitani, K., Tsubokawa, N., Miyata, Y., Takeshima, Y., & Okada, M. (2024). Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17352
Vancouver
Fujiwara M, Mimae T, Kushitani K, Tsubokawa N, Miyata Y, Takeshima Y, et al. Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma. Anticancer Research. 2024. doi:10.21873/anticanres.17352
BibTeX
@article{Fujiwara2024,
author = {Fujiwara, Makoto and Mimae, Takahiro and Kushitani, Kei and Tsubokawa, Norifumi and Miyata, Yoshihiro and Takeshima, Yukio and Okada, Morihito},
title = {Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17352}
}
EUVIMED